Cargando…
Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations
Because the treatment of multiple sclerosis (MS) may span decades, the need often arises to make changes to the treatment plan in order to accommodate changing circumstances. Switching drugs, or the discontinuation of immunomodulatory agents altogether, may leave patients vulnerable to relapse or di...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858914/ https://www.ncbi.nlm.nih.gov/pubmed/31677060 http://dx.doi.org/10.1007/s40120-019-00160-9 |